Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15205 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Xingchen Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Hyperuricemia, Atherosclerosis, Uric Acid, Predictive Value of Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Shanghai Hospital Development Center, the National Natural Science Foundation of China, Shanghai Municipal Hospital Development Center.
Abstract (Originalsprache)
Objective
To construct a risk prediction model for atherosclerotic cardiovascular disease (ASCVD) in patients with hyperuricemia.
Methods
Data in this study were obtained from the National Health and Nutrition Examination Survey (NHANES) (2007–2010). Participants from Huashan Hospital were included as an external validation. Logistic regression analysis was used to explore the relevant factors of ASCVD in patients with hyperuricemia. The discriminability of the model was evaluated using the area under the curve (AUC) statistic of the receiver operating characteristic curve. Hosmer–Lemeshow test, correction curve and decision curve analysis (DCA) were used to evaluate the model.
Results
A total of 389 patients collected from the NHANES were included in the final analysis. Logistic regression analysis showed that age, creatinine (Cr), glucose (Glu), serum uric acid (SUA), and history of gout were predictive factors for ASCVD in hyperuricemia (HUA) patients. These predictive factors were used to construct a nomogram. And 157 patients from NHANES were in the internal validation group and 136 patients from Huashan Hospital were in the external validation group. The AUC values of the three groups were 0.943, 0.735, and 0.664. The p values of the Hosmer–Lemeshow test were .568, .600, and .763. The calibration curve showed consistency between the nomogram and the actual observed values. The DCA curve indicated that the model has good clinical practicality.
Conclusion
This study constructed the ASCVD risk prediction model for HUA patients, which is beneficial for medical staff to detect high‐risk populations of ASCVD in the early stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Xingchen Du, HaiFeng Pan
Förderung
- Shanghai Hospital Development Center
- the National Natural Science Foundation of China
- Shanghai Municipal Hospital Development Center
- National Natural Science Foundation of China
Zitieren
APA
Du, X., Chen, F., He, Y., Zou, H., Pan, H., & Zhu, X. (2024). Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15205
Vancouver
Du X, Chen F, He Y, Zou H, Pan H, Zhu X. Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15205
BibTeX
@article{Du2024,
author = {Du, Xingchen and Chen, Fangfang and He, Yisheng and Zou, Hejian and Pan, HaiFeng and Zhu, Xiaoxia},
title = {Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15205}
}
EUVIMED